相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Adenovirus-prime and baculovirus-boost heterologous immunization achieves sterile protection against malaria sporozoite challenge in a murine model
Kunitaka Yoshida et al.
SCIENTIFIC REPORTS (2018)
Baculovirus-Induced Fast-Acting Innate Immunity Kills Liver-Stage Plasmodium
Talha Bin Emran et al.
JOURNAL OF IMMUNOLOGY (2018)
Fight fire with fire: Gene therapy strategies to cure HIV
Jon Huyghe et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2017)
Unraveling the Complex Story of Immune Responses to AAV Vectors Trial After Trial
Celine Vandamme et al.
HUMAN GENE THERAPY (2017)
Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial
Feng-Cai Zhu et al.
LANCET (2017)
DAF-shielded baculovirus-vectored vaccine enhances protection against malaria sporozoite challenge in mice
Mitsuhiro Iyori et al.
MALARIA JOURNAL (2017)
Protective efficacy of an IL-12-expressing baculoviral malaria vaccine
M. Iyori et al.
PARASITE IMMUNOLOGY (2017)
Molecular definition of multiple sites of antibody inhibition of malaria transmission-blocking vaccine antigen Pfs25
Stephen W. Scally et al.
NATURE COMMUNICATIONS (2017)
A whole parasite transmission-blocking vaccine for malaria: an ignored strategy
Michael F. Good et al.
EMERGING TOPICS IN LIFE SCIENCES (2017)
Implementation of the malaria candidate vaccine RTS,S/AS01
Brian Greenwood et al.
LANCET (2016)
Sustained Expression with Partial Correction of Neutrophil Defects 5 Years After Intramuscular rAAV1 Gene Therapy for Alpha-1 Antitrypsin Deficiency
Christian Mueller et al.
MOLECULAR THERAPY (2016)
Seven-Year Efficacy of RTS, S/AS01 Malaria Vaccine among Young African Children
Ally Olotu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Transmission-blocking activity is determined by transmission-reducing activity and number of control oocysts in Plasmodium falciparum standard membrane-feeding assay
Kazutoyo Miura et al.
VACCINE (2016)
Safety and Immunogenicityof Pfs25-EPA/Alhydrogel® , a Transmission Blocking Vaccine against Plasmodium falciparum: An Open Label Study in Malaria Naive Adults
Kawsar R. Talaat et al.
PLOS ONE (2016)
Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial
H. Tinto et al.
LANCET (2015)
Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial
Michael T. White et al.
LANCET INFECTIOUS DISEASES (2015)
Recent advances in recombinant protein-based malaria vaccines
Simon J. Draper et al.
VACCINE (2015)
Vectored immunoprophylaxis protects humanized mice from mucosal HIV transmission
Alejandro B. Balazs et al.
NATURE MEDICINE (2014)
Vectored antibody gene delivery protects against Plasmodium falciparum sporozoite challenge in mice
Cailin Deal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
AAV vectors vaccines against infectious diseases
Karen Nieto et al.
FRONTIERS IN IMMUNOLOGY (2014)
Functional Comparison of Plasmodium falciparum Transmission-Blocking Vaccine Candidates by the Standard Membrane-Feeding Assay
Kazutoyo Miura et al.
INFECTION AND IMMUNITY (2013)
Visualization and live imaging analysis of a mosquito saliva protein in host animal skin using a transgenic mosquito with a secreted luciferase reporter system
D. S. Yamamoto et al.
INSECT MOLECULAR BIOLOGY (2013)
Malaria vaccine technology roadmap
Vasee S. Moorthy et al.
LANCET (2013)
Broad protection against influenza infection by vectored immunoprophylaxis in mice
Alejandro B. Balazs et al.
NATURE BIOTECHNOLOGY (2013)
Protective Efficacy of Baculovirus Dual Expression System Vaccine Expressing Plasmodium falciparum Circumsporozoite Protein
Mitsuhiro Iyori et al.
PLOS ONE (2013)
Development of a Pfs25-EPA malaria transmission blocking vaccine as a chemically conjugated nanoparticle
Richard L. Shimp et al.
VACCINE (2013)
Transmission-blocking interventions eliminate malaria from laboratory populations
A. M. Blagborough et al.
NATURE COMMUNICATIONS (2013)
Improved adeno-associated virus (AAV) serotype 1 and 5 vectors for gene therapy
Dwaipayan Sen et al.
SCIENTIFIC REPORTS (2013)
Antibody-based protection against HIV infection by vectored immunoprophylaxis
Alejandro B. Balazs et al.
NATURE (2012)
Algae-Produced Pfs25 Elicits Antibodies That Inhibit Malaria Transmission
James A. Gregory et al.
PLOS ONE (2012)
Malaria vaccines: Focus on adenovirus based vectors
Nathaniel J. Schuldt et al.
VACCINE (2012)
Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges
Federico Mingozzi et al.
NATURE REVIEWS GENETICS (2011)
A Viral Vectored Prime-Boost Immunization Regime Targeting the Malaria Pfs25 Antigen Induces Transmission-Blocking Activity
Anna L. Goodman et al.
PLOS ONE (2011)
A Research Agenda for Malaria Eradication: Drugs
Pedro L. Alonso et al.
PLOS MEDICINE (2011)
Prevalence of Serum IgG and Neutralizing Factors Against Adeno-Associated Virus (AAV) Types 1, 2, 5, 6, 8, and 9 in the Healthy Population: Implications for Gene Therapy Using AAV Vectors
Sylvie Boutin et al.
HUMAN GENE THERAPY (2010)
That Was Then But This Is Now: Malaria Research in the Time of an Eradication Agenda
Stefan H. I. Kappe et al.
SCIENCE (2010)
The IC50 of anti-Pfs25 antibody in membrane-feeding assay varies among species
Lediya Cheru et al.
VACCINE (2010)
Worldwide Epidemiology of Neutralizing Antibodies to Adeno-Associated Viruses
Roberto Calcedo et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Transgenic Rodent Plasmodium berghei Parasites as Tools for Assessment of Functional Immunogenicity and Optimization of Human Malaria Vaccines
Godfree Mlambo et al.
EUKARYOTIC CELL (2008)
Evaluation and optimization of membrane feeding compared to direct feeding as an assay for infectivity
Mouctar Diallo et al.
MALARIA JOURNAL (2008)
Display of heterologous proteins on gp64null baculovirus virions and enhanced budding mediated by a vesicular stomatitis virus G-stem construct
Jian Zhou et al.
JOURNAL OF VIROLOGY (2008)
Transmission-blocking activity induced by malaria vaccine candidates Pfs25/Pvs25 is a direct and predictable function of antibody titer
Kazutoyo Miura et al.
MALARIA JOURNAL (2007)
Effect of preexisting immunity to adenovirus human serotype 5 antigens on the immune responses of nonhuman primates to vaccine regimens based on human- or chimpanzee-derived adenovirus vectors
Kimberly McCoy et al.
JOURNAL OF VIROLOGY (2007)
AAV vectors encoding malarial antigens stimulate antigen-specific immunity but do not protect from parasite infection
Grant J. Logan et al.
VACCINE (2007)
Induction of robust immune responses against human immunodeficiency virus is supported by the inherent tropism of adeno-associated virus type 5 for dendritic cells
Ke-Qin Xin et al.
JOURNAL OF VIROLOGY (2006)
Intranasal vaccination with recombinant adeno-associated virus type 5 against human papillomavirus type 16 L1
D Kuck et al.
JOURNAL OF VIROLOGY (2006)
Gene transfer into skeletal muscle using novel AAV serotypes
JP Louboutin et al.
JOURNAL OF GENE MEDICINE (2005)
Evaluation of the standard membrane feeding assay (SMFA) for the determination of malaria transmission-reducing activity using empirical data
M Van Der Kolk et al.
PARASITOLOGY (2005)
Prevalence of neutralizing antibodies to adenoviral serotypes 5 and 35 in the adult populations of The Gambia, South Africa, and the United States
E Nwanegbo et al.
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY (2004)
Merozoite surface protein 4/5 provides protection against lethal challenge with a heterologous malaria parasite strain
MW Goschnick et al.
INFECTION AND IMMUNITY (2004)
Plasmodium falciparum:: glycosylation status of Plasmodium falciparum circumsporozoite protein expressed in the baculovirus system
MH Kedees et al.
EXPERIMENTAL PARASITOLOGY (2002)
分享论文
